AMS AMS-OSRAM AG

Elevating CT Technology: Photon Counting and Cost-Efficient Sensor Modules From ams OSRAM

With two new sensor modules, , a global leader in intelligent sensors and emitters, demonstrates its commitment to Computed Tomography (CT). At the heart of this diagnostic imaging technology are CT sensor modules that support clinical applications from oncology to the treatment of cardiovascular conditions, ensuring precise patient outcomes and enabling early diagnosis. The new products advance the medical imaging technology across the CT market segments. For the premium CT segment, ams OSRAM introduces a new System-in-Package sensor module designed for photon counting detectors, delivering a substantial reduction in the radiation dose and additional diagnostic value. For the price-sensitive CT segment, ams OSRAM presents a new sensor module, ensuring high-quality medical imaging at a competitive price.

“ams OSRAM is making both cutting-edge and cost-efficient sensor modules broadly available for high-resolution, information-rich, and low-dose CT scans. Our powerful but affordable sensor module enhances the accessibility of modern CT technology while delivering significant performance improvements. With its new photon counting detector, our company is playing a key role in driving the next revolution in medical imaging, elevating medical treatments to a new level,” emphasizes Ivo Ivanovski, Head of Product Line Medical Imaging & Foundry at ams OSRAM.

For more information on the , the first disruptive package solution for photon counting detectors and , an affordable, high-performance sensor module for 64-slice CT imaging, please refer to the .

EN
18/02/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on AMS-OSRAM AG

Carole Braudeau
  • Carole Braudeau

Credit Morning 05/12/2025

Pharma: Donald Trump wants to cut the price of prescription drugs|ams OSRAM launches a consent request to amend the convertible notes|MPS published strong Q1 2025 results /the offer for Bacred is proceeding according to schedule|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 12/05/2025

Pharma : Donald Trump veut réduire le prix des médicaments sur ordonnance|ams OSRAM lance une demande de consentement visant les obligations convertibles|MPS a publié de solides résultats T1 2025 et poursuit son offre sur Mediobanca|

Carole Braudeau
  • Carole Braudeau

Credit Morning 04/30/2025

Flos B&B Italia: after strong Q4 results, the start of the year is proving much more difficult|ams OSRAM: Q1 2025 results ahead of expectations, strategic options considered for certain assets|Viridien: a good set of Q1 2025 results, and FY 2025 FCF guidance confirmed|

ResearchPool Subscriptions

Get the most out of your insights

Get in touch